Emphasizes standardizing spinal cord imaging to improve trial outcomes in multiple sclerosis, suggesting vital improvements.
A very small proportion of clinical trials have used SC MRI metrics as outcome measures. Given the substantial impact of SC disease on disability, it is essential to standardize SC imaging, post-processing, and analytical methods across centres to enhance the effectiveness and applicability of SC MRI in future clinical trials.
No takes yet. Share an insight, caveat, or question.
Toubasi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: